alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 3093 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 3093

To extend the temporary suspension of duty on acrylic staple fiber, not 
 dyed, not carded, combed, or otherwise processed for spinning, with a 
  cut fiber length of 100 mm to 135 mm and a target length of 120 mm.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 10, 2012

  Mrs. Hagan introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To extend the temporary suspension of duty on acrylic staple fiber, not 
 dyed, not carded, combed, or otherwise processed for spinning, with a 
  cut fiber length of 100 mm to 135 mm and a target length of 120 mm.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ACRYLIC STAPLE FIBER, NOT DYED, NOT CARDED, COMBED, OR 
              OTHERWISE PROCESSED FOR SPINNING, WITH A CUT FIBER LENGTH 
              OF 100 MM TO 135 MM AND A TARGET LENGTH OF 120 MM.

    (a) In General.--Heading 9902.40.31 of the Harmonized Tariff 
Schedule of the United States (relating to acrylic staple fiber, not 
dyed, not carded, combed, or otherwise processed for spinning, with a 
cut fiber length of 100 mm to 135 mm and a target length of 120 mm) is 
amended by striking the date in the effective period column and 
inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

WASHINGTON, D.C. 20460

 OFFICE OF

PREVENTION, PESTICIDES

AND TOXIC SUBSTANCES

MEMORANDUM

Date/Time: August 6, 2014 / 2:00 p.m. – 3:00 p.m.

Subject: Paraquat Dichloride Meeting Minutes. OPP Meets with Technical 

Registrants of Paraquat Dichloride to Address Incidents Associated with 

Paraquat Dichloride Ingestion Resulting in Deaths and Discuss Mitigation 

Options and Implementation.

From: Marianne A. Mannix, Chemical Review Manager

Re-evaluation Management and Implementation Branch III

Pesticide Re-evaluation Division (7508P)

Participants: Patricia Parrott (EPA), Avivah Jakob (EPA), Marianne Mannix (EPA), 

Derek Berwald (EPA), Nancy Fitz (EPA), Shanna Recore (EPA), Elissa 

Reaves (EPA), Dan Kenny (EPA), Sunil Ratnayake (EPA), Bill Chism 

(EPA), Sarah Meadows (EPA), Norman Spurling (EPA), David Miller 

(EPA), Elizabeth Evans (EPA), Monty Dixon (Syngenta), Jerry Wells 

(Syngenta), Michelle Wall (Syngenta), Angela Hofstra (Syngenta), John 

Abbott (Syngenta), Kelly Powell (Celcius), Jan Stechmann (Helm Agro), 

Sebastian Lueth (Helm Agro), K.C. Lin (Sinon), Larry Miller (Sinon)

Meeting Minutes:

The Environmental Protection Agency’s (EPA) Office of Pesticide Programs (OPP) 

requested a meeting with the technical registrants of paraquat dichloride to discuss 

reported human health incidents, including deaths due to ingestion of the pesticide. The 

goal of the meeting was to discuss mitigation options and implementation. Technical 

registrants of paraquat dichloride include: Syngenta Crop Protection LLC, Celcius 

Property B.V., Amsterdam (NL), Helm Agro US Inc., Sharda Cropchem Limited, Sinon 

Corporation, Source Dynamics, US Raymat, and Willowood Paraquat LLC. Monty 

Dixon and Jerry Wells of Syngenta attended the meeting in person, and representatives 

for the other technical registrants participated in the meeting through a conference line. 

EPA met with the technical registrants of paraquat dichloride on August 6, 2014. During 

the meeting, EPA provided a review of the registration review schedule for paraquat 

dichloride. EPA reviewed the history of incidents associated with paraquat according to 

the May 21, 2014 Memorandum entitled Paraquat Dichloride: Review of Human 

Ingestion Incidents. Between 1990 and February 2014, 276 incidents involving paraquat 

dichloride were reported; 27 of which resulted in fatalities. EPA and the Registrants 

acknowledged the fact that the majority of these incidents have occurred as a result of 
non-adherence to the labeled use of paraquat dichloride products. EPA and the 

Registrants believe that the high severity and occurrence of incidents calls for immediate 

attention and action outside of the typical registration review process. There was a 

discussion of potential mitigation measures and their feasibility. In the meeting, it was 

agreed that the registrants will submit mitigation proposals to the Agency within the next 

month. OPP will continue discussions with the registrants to assist in the preparation of 

mitigation proposals and their implementation.
QuickLinks
 -- Click here to rapidly navigate through this document











 



 
 

Exhibit 10.51    
    


         

  


February 22,
2008 


John
J. Peterman

c/o iPCS, Inc.

1901 N. Roselle Road

Schaumburg, IL 60195 


Dear
Mr. Peterman: 


        Reference
is made to the Employment Agreement, dated as of March 7, 2007 (the "Employment Agreement"), between you and iPCS Wireless, Inc. Capitalized terms used herein but
not defined herein shall have the meanings set forth in the Employment Agreement. 


        I
am pleased to inform you that the Compensation Committee of the Board of Directors took the following actions effective January 1, 2008: 



	•
	Increased
your Annual Base Salary to $245,000.



	•
	Increased
your Incentive Bonus under the Incentive Bonus Plan at the target level of performance to 50% of your Annual Base Salary.



	•
	Amended
and restated in their entirety clauses (a) and (b) of paragraph 1 of Exhibit A to the
Employment Agreement to read as follows: 





"(a)    a
lump sum payment equal to 150% of Executive's Annual Base Salary; 


(b)    continuation
of health benefits for Executive and Executive's qualified beneficiaries for the period beginning on the Termination Date and ending on the 18-month
anniversary of the Termination Date at a cost which is no greater than is charged to active employees of the Company and their dependents, which continuing health benefits shall be provided only if
Executive and Executive's qualified beneficiaries, as applicable, make a timely and proper election to be covered under COBRA;" 





        This
constitutes an amendment of your Employment Agreement. Please acknowledge this amendment by countersigning below. 



	

 	

 	

Very truly yours,
	

 	

 	
iPCS, Inc.
	

 	

 	

By:	

/s/ Edmund L. Quatmann, Jr.

	 	 	Name:  Edmund L. Quatmann, Jr.
	 	 	Title:    Vice President and General Counsel
	

AGREED AND ACKNOWLEDGED

this 22nd day of February, 2008	

 	

 
	

By:	

/s/ John J. Peterman
	

 	

 













QuickLinks



Exhibit 10.51
<PAGE>   1



                             VIRCO MFG. CORPORATION

         Exhibit (11) - Statement re: Computation of Earnings Per Share


<TABLE>
<CAPTION>

                                                           Three Months Ended                 Six Months Ended
                                                                July 31                           July 31
                                                      ----------------------------      ----------------------------
                                                         2001              2000             2001             2000
                                                      -----------      -----------      -----------      -----------
<S>                                                   <C>              <C>              <C>              <C>
Diluted earnings per share

Average shares outstanding                             12,238,000       12,494,000       12,329,000       12,498,000

Net effect of dilutive stock options -
based on treasury stock
method using average market price                         129,000          157,000          129,000          152,000
                                                      -----------      -----------      -----------      -----------
Totals                                                 12,367,000       12,651,000       12,458,000       12,650,000
                                                      ===========      ===========      ===========      ===========

Net income before cumulative effect of change in      $ 4,490,000      $ 4,262,000      $   725,000      $ 6,582,000
                                                      ===========      ===========      ===========      ===========
accounting principle

Per share amount before cumulative effect
of change in accounting principle                     $       .36      $       .34      $       .06      $       .52
                                                      ===========      ===========      ===========      ===========

</TABLE>


Weighted average shares outstanding for the three months and six months ended
July 31, 2000 were adjusted for 10% stock dividend declared August 21, 2001.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 3126 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 3126

  To extend the temporary suspension of duty on acrylic staple fibers 
 (polyacrylonitrile staple) containing 85 percent or more by weight of 
  acrylonitrile units and 2 percent or more but not over 3 percent of 
 water, not pigmented (ecru), crimped, with an average decitex of 1.3 
(plus or minus 10 percent) and fiber length of 40 mm (plus or minus 10 
                               percent).

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 10, 2012

  Mrs. Hagan introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To extend the temporary suspension of duty on acrylic staple fibers 
 (polyacrylonitrile staple) containing 85 percent or more by weight of 
  acrylonitrile units and 2 percent or more but not over 3 percent of 
 water, not pigmented (ecru), crimped, with an average decitex of 1.3 
(plus or minus 10 percent) and fiber length of 40 mm (plus or minus 10 
                               percent).

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ACRYLIC STAPLE FIBERS (POLYACRYLONITRILE STAPLE) CONTAINING 
              85 PERCENT OR MORE BY WEIGHT OF ACRYLONITRILE UNITS AND 2 
              PERCENT OR MORE BUT NOT OVER 3 PERCENT OF WATER, NOT 
              PIGMENTED (ECRU), CRIMPED, WITH AN AVERAGE DECITEX OF 1.3 
              (PLUS OR MINUS 10 PERCENT) AND FIBER LENGTH OF 40 MM 
              (PLUS OR MINUS 10 PERCENT).

    (a) In General.--Heading 9902.40.11 of the Harmonized Tariff 
Schedule of the United States (relating to acrylic staple fibers 
(polyacrylonitrile staple) containing 85 percent or more by weight of 
acrylonitrile units and 2 percent or more but not over 3 percent of 
water, not pigmented (ecru), crimped, with an average decitex of 1.3 
(plus or minus 10 percent) and fiber length of 40 mm (plus or minus 10 
percent)) is amended by striking the date in the effective period 
column and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
Exhibit 21


                     SUBSIDIARIES OF BARNEYS NEW YORK, INC.

                                AS OF MAY 1, 2003


<TABLE>
<CAPTION>
                                            STATE (OR JURISDICTION) IN WHICH     APPROXIMATE PERCENTAGE OF VOTING SECURITIES
                  NAME                         INCORPORATED (OR ORGANIZED)                OWNED BY IMMEDIATE PARENT
                  ----                         ---------------------------                -------------------------
<S>                                          <C>                                  <C>

Barney's, Inc.                                          New York                                     100%

Barneys America, Inc. (1)                               Delaware                                     100%

Barneys America (Chicago) Lease Corp. (2)               Delaware                                     100%

BNY Licensing Corp. (1)                                 Delaware                                     100%

Barneys Asia Co LLC (3)                                 Delaware                                      70%

Barneys (CA) Lease Corp. (1)                            Delaware                                     100%

Barneys (NY) Lease Corp. (1)                            Delaware                                     100%

Basco All-American Sportswear Corp. (1)                 New York                                     100%

</TABLE>




------------------------------------

(1) Subsidiary of Barney's, Inc.

(2) Subsidiary of Barneys America, Inc.

(3) Subsidiary of BNY Licensing Corp.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS OF CITADEL TECHNOLOGY, INC. FOR THE SIX MONTHS
ENDED AUGUST 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
CONSOLIDATED FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          FEB-28-1999
<PERIOD-START>                             MAR-01-1999
<PERIOD-END>                               AUG-31-1999
<CASH>                                          81,045
<SECURITIES>                                         0
<RECEIVABLES>                                1,839,839
<ALLOWANCES>                                 1,058,245
<INVENTORY>                                    149,862
<CURRENT-ASSETS>                             1,474,356
<PP&E>                                         967,341
<DEPRECIATION>                                 623,751
<TOTAL-ASSETS>                              17,811,725
<CURRENT-LIABILITIES>                        1,743,944
<BONDS>                                              0
<PREFERRED-MANDATORY>                                1
<PREFERRED>                                          0
<COMMON>                                       473,369
<OTHER-SE>                                  15,594,411
<TOTAL-LIABILITY-AND-EQUITY>                17,811,725
<SALES>                                      1,102,392
<TOTAL-REVENUES>                             1,102,392
<CGS>                                           47,777
<TOTAL-COSTS>                                   47,777
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,120
<INCOME-PRETAX>                            (4,696,204)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (4,696,204)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (4,696,204)
<EPS-BASIC>                                      (.11)
<EPS-DILUTED>                                    (.11)


</TABLE>
Exhibit 99.1



Statement of Chief Executive Officer

Pursuant to Section 1350 of Title 18 of the United States Code



Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Michael J. Hagan, the Chairman of the Board and Chief
Executive Officer of NutriSystem, Inc. (the Company), hereby certifies that:



| | 1) |  | The Companys Form 10-Q Quarterly Report for the period ended March 31, 2003 (the Report) fully complies with the requirements of Section 13(a) of
the Securities Exchange Act of 1934; and
| | -- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2) |  | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------







|                 
|-----------------
|Date: May 2, 2003
|
Michigan Supreme Court

Lansing, Michigan

Bridget M. McCormack, Chief Justice

David F. Viviano,

Chief Justice Pro Tem

Stephen J. Markman

Brian K. Zahra

Richard H. Bernstein

Elizabeth T. Clement

Megan K. Cavanagh,

Justices

I, Larry S. Royster, Clerk of the Michigan Supreme Court, certify that the

foregoing is a true and complete copy of the order entered at the direction of the Court.

 July 15, 2020

p0715

Order 

Clerk

July 15, 2020

154773 (92)

PEOPLE OF THE STATE OF MICHIGAN,

Plaintiff-Appellee,

v SC: 154773

COA: 325662

Macomb CC: 2009-005244-FC

IHAB MASALMANI,

Defendant-Appellant.

_____________________________________/

On order of the Court, the motion for reconsideration of this Court’s May 29, 2020 

order is considered, and it is DENIED, because we are not persuaded that reconsideration 

of our previous order is warranted. MCR 7.311(G).
---

|CERTIFICATION OF                             
|---------------------------------------------
|CHIEF EXECUTIVE OFFICER AND                  
|CHIEF FINANCIAL OFFICER                      
|PURSUANT TO                                  
|18 U.S.C. SECTION 1350,                      
|AS ADOPTED PURSUANT TO                       
|SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Vernon Samaroo, Chief Executive Officer and Chief Financial
Officer of Southridge Enterprises Inc. (the Company), hereby certify pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

| | (i)  | the Annual Report on Form 10-KSB of the Company, for the
      fiscal year ended August 31, 2005, and to which this certification is
      attached as Exhibit 32.1 (the Report) fully complies with the
      requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
      1934, as amended; and
| | ---- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |      |                                                                                                                                                                                                                                                                                                                      
| | (ii) | the information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of the Company.                                                                                                                                                     

| | By:    | /s/ *Vernon Samaroo*   
| | ------ | -----------------------
| | Name:  | **VERNON SAMAROO**     
| | Title: | Chief Executive Officer
| |        | Chief Financial Officer
| |        |                        
| | Date:  | December 16, 2005      

A signed original of this written statement required by
Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the
Registrant and will be retained by the Registrant and furnished to the
Securities and Exchange Commission or its staff upon request.

This certification accompanies the Form 10-KSB to which it
relates, is not deemed filed with the Securities and Exchange Commission and is
not to be incorporated by reference into any filing of the Registrant under the
Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made
before or after the date of the Form 10-KSB), irrespective of any general
incorporation language contained in such filing.

---
exv4w8w4






Exhibit 4.8.4





FOURTH
JOINDER TO THE REGISTRATION RIGHTS AGREEMENT



     With respect to the Registration Rights Agreement, (the “Registration Rights Agreement”) dated
as of May 4, 2010, among Reynolds Group Issuer LLC, a Delaware limited liability company (the “US
Issuer I”), Reynolds Group Issuer Inc., a Delaware corporation (the “US Issuer II”), Reynolds Group
Issuer (Luxembourg) S.A., a société anonyme (limited liability company) organized under the laws of
Luxembourg (the “Luxembourg Issuer” and, together with US Issuer I and US Issuer II, the
“Issuers”), the Closing Date Guarantors and Credit Suisse Securities (USA) LLC, as the Purchaser,
for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,
the signatory hereto (i) hereby agrees to become a party to the Registration Rights Agreement as a
Guarantor with the same force and effect as if originally named a Closing Date Guarantor therein
and (ii) without limiting the generality of the foregoing, assumes all of the rights and
obligations of the Guarantors under the Registration Rights Agreement, in each case, as of the time
of delivery of this Fourth Joinder to the Registration Rights Agreement on August 5, 2011, as
though it had entered into the Registration Rights Agreement on May 4, 2010. The obligations
assumed by the Guarantor under this Fourth Joinder to the Registration Rights Agreement shall be
joint and several obligations. Capitalized terms used but not defined in this Fourth Joinder to
the Registration Rights Agreement shall have the meanings given to such terms in the Registration
Rights Agreement.






 









 









     IN WITNESS WHEREOF, the undersigned has executed this Joinder on the above referenced date.





	 	 	 	 	 	 	 

	 	 	
SIG COMBIBLOC LTD.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Chiara Brophy
 

Chiara Brophy
	 	 
	 

	 	Title:
	 	Authorized Signatory	 	 












Joinder to the May 2010
Notes Registration Rights Agreement